ESR1 and prostate carcinoma: Actually, tectorigenin has been proven to be a selective estrogen-receptor modulator that could bind to estrogen receptors ERα and Erβ, with a higher affinity for Erβ, and prevent the proliferation of some hormone-dependent prostate cancer cells [73,74].